World Bank bars Famy Care, Olive Healthcare from receiving its contractsPost published:August 5, 2017Post category:Industry NewsA World Bank investigation has found that pharma firms Famy Care and Olive Healthcare engaged in ‘fraud’ and ‘misconduct’ Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostDigital transactions gain momentum, shows RBI data Next PostONGC buys 80% participating interest in GSPC block You Might Also Like HARTING introduces Han 1a industrial connector April 1, 2019 Drug firms demand NPPA withdraw notices alleging overcharging August 30, 2017 Digital Safety for the Energy Industry: Inside Siemens & TÜV SÜD’s cybersecurity partnership May 20, 2019
Digital Safety for the Energy Industry: Inside Siemens & TÜV SÜD’s cybersecurity partnership May 20, 2019